The beneficial effect of Escalated‐R‐CHOP‐21 for the treatment of diffuse large B‐cell lymphoma in elderly male patients: A propensity‐matched cohort study

PURPOSE: Some studies have indicated that using 500 mg/m(2) rituximab combined with CHOP‐14 may be beneficial for elderly men but not women with diffuse large B‐cell lymphoma (DLBCL). The purpose of this study was to investigate the potential benefit of escalated doses of rituximab with CHOP‐21 as t...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Hai‐Xia, Gao, Yan, Bai, Bing, Wang, Xiao‐Xiao, Li, Ji‐Bin, Huang, Cheng, Mao, Jia‐Ying, Ping, Li‐Qin, Rong, Qi‐Xiang, He, Yan‐Xia, Huang, He, Cai, Qing‐Qing, Li, Zhi‐Ming, Jiang, Wen‐Qi, Huang, Hui‐Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559475/
https://www.ncbi.nlm.nih.gov/pubmed/34581023
http://dx.doi.org/10.1002/cam4.4296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559475/
https://www.ncbi.nlm.nih.gov/pubmed/34581023
http://dx.doi.org/10.1002/cam4.4296

Ejemplares similares